Lupin Limited has launched Doxycycline for Injection USP in the U.S., marking a key addition to the market of antibiotics. This approval by the U.S. FDA provides a generic alternative to Pfizer's Vibramycin. Manufactured in India, this injection addresses bacterial infections and supports maintaining the effectiveness of antibiotics.